Archive | Melanoma News

The National Comprehensive Cancer Network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients

In patients with uveal melanoma, researchers evaluated quality of life (QoL) status through the National Comprehensive Cancer Network (NCCN) distress thermometer as a psycho-oncological screening tool.

Read the full story

Posted in Melanoma News, Publications, Scientific Publications

Lentigo Maligna Clinical Practice Guidelines (2019)

The diagnosis of lentigo maligna is made using the results from biopsy and histopathology studies. Because the risk of lentigo maligna progressing to invasive melanoma generally is low and can take many years, watchful waiting (monitoring the lesions over time) may be a more appropriate approach in very elderly patients or those with significant comorbidities.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the benefits of immunotherapy, specifically the combination of the CTLA-4 inhibitoripilimumab (Yervoy) and the PD-1 inhibitor nivolumab (Opdivo), in melanoma.

Read the full story

Posted in Melanoma News, Health Professionals, Video Reports

Response to Initial Immunotherapy Treatment Predicts Melanoma Outcomes

I’m Dr Jeffrey Weber, deputy director of the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health in New York City.

Read the full story

Posted in Melanoma News, Health Professionals, Of Interest